Stem cell therapy fails to improve kidney rejection, raises safety flags
NCT ID NCT07005687
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tested whether a person's own stem cells (mesenchymal stem cells) could help treat chronic active antibody-mediated rejection in kidney transplant recipients. Only 3 patients were enrolled before the study was stopped early due to serious side effects. The treatment did not improve rejection, and one patient experienced severe complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.